Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
23 June, 2017 08:45 IST
Aurobindo Pharma gets USFDA nod for anti-cough tablets
Source: IRIS | 21 Mar, 2017, 09.14AM
Comments  |  Post Comment

Aurobindo Pharma announced that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets, 600/30 mg and 1200/60mg (OTC). Aurobindo's Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets are the AB rated generic equivalent of Reckitt Benckiser's Mucinex DM tablets. The product will be launched in Q1FY18.

Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets helps loosen mucus and phlegm, and thin out bronchial secretions, making coughs more productive. The approved product has an estimated market size of US$ 235 million for the twelve months ending December 2016 according to IRI database.

This is the 106 th ANDA (including 21 tentative approvals) approved out of Unit VII formulation facility in Hyderabad, India used for manufacturing oral products. Aurobindo now has a total of 311 ANDA approvals (272 Final approvals including 16 from Aurolife Pharma LLC and 39 tentative approvals) from USFDA.

Shares of the company gained Rs 1.7, or 0.24%, to trade at Rs 704.90. The total volume of shares traded was 0 at the BSE (9.01 a.m., Tuesday).



Aurobindo Pharma Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Strides Shasun, Vivimed Labs achieve closure to set up JV in India, Singapore - 22-Jun-2017 14:26
PI Industries enters into JV agreement with Kumiai Chemical - 22-Jun-2017 14:22
Lupin launches generic Topicort LP Emollient Cream, Topicort cream in US - 22-Jun-2017 14:17
Prism Cement's arm completes expansion of vitrified tiles capacity at Morbi - 22-Jun-2017 10:27
Nila Infra bags work order worth Rs 251.6 mn from AMC - 22-Jun-2017 10:25
NHPC inks MoU with Ministry of Power for 2017-18 - 22-Jun-2017 10:21
Glenmark Pharma gets tentative approval for generic Vesicare tablets - 22-Jun-2017 10:11
Alembic Pharma receives USFDA nod for Amantadine HCl capsules - 22-Jun-2017 10:04
HDFC Bank partners with ZineOne for rich digital banking experience - 21-Jun-2017 16:04
Reliance Defence to form JV with French Co Thales - 21-Jun-2017 14:04
Reliance Defence to form JV with French Co Thales - 21-Jun-2017 14:04
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer